# Budesonide Inhalation Suspension for Acute Asthma in Children

> **NCT00393367** · PHASE4 · COMPLETED · sponsor: **Children's Hospital of Philadelphia** · enrollment: 179 (actual)

## Conditions studied

- Asthma
- Acute Asthma
- Reactive Airway Exacerbation

## Interventions

- **DRUG:** Budesonide inhalation suspension (0.5 mg/2mL) 2mg, albuterol (5mg/mL) 7.5 or 10mg
- **DRUG:** Prednisolone, prednisone, or methylprednisolone
- **DRUG:** Albuterol, ipratropium bromide
- **DRUG:** Ipratropium bromide

## Key facts

- **NCT ID:** NCT00393367
- **Lead sponsor:** Children's Hospital of Philadelphia
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-12
- **Primary completion:** 2007-11
- **Final completion:** 2007-11
- **Target enrollment:** 179 (ACTUAL)
- **Last updated:** 2012-08-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00393367

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00393367, "Budesonide Inhalation Suspension for Acute Asthma in Children". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00393367. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*